Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Nemonoxacin's preclinical profile reported

Oct. 3, 2007

Preclinical efficacy, pharmacokinetics and safety of the ETB agonist SPI-1620

Oct. 3, 2007

Local delivery of VIP-loaded liposomes effectively protects ocular tissue in rats with EAU

Oct. 3, 2007

Osteopontin: a novel target for the treatment of uveoretinitis

Oct. 3, 2007

Minodronate effective in Japanese women with postmenopausal osteoporosis

Oct. 3, 2007

Positive preclinical results of the anti-varicella zoster virus agent FV-100

Oct. 2, 2007

Preclinical results of VEL-0230, a dual-action cathepsin K inhibitor, reported

Oct. 2, 2007

Inhibition of MarA virulence factor increases survival in Pseudomonas aeruginosa pneumonia model

Oct. 2, 2007

UK-500,001 ineffective in asthma, COPD studies

Oct. 2, 2007

Study reveals advantages of insulin VIAject over insulin lispro, regular insulin

Oct. 2, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 10, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026